Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | RGT-018 |
| Trade Name | |
| Synonyms | RGT 018|RGT018 |
| Drug Descriptions |
RGT-018 selectively inhibits SOS1, potentially resulting in decreased tumor cell proliferation and reduced tumor growth (PMID: 39087485). |
| DrugClasses | SOS1 Inhibitor 17 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Abemaciclib + RGT-018 | Abemaciclib RGT-018 | 0 | 0 |
| Adagrasib + RGT-018 | Adagrasib RGT-018 | 0 | 0 |
| Afatinib + RGT-018 | Afatinib RGT-018 | 0 | 0 |
| Cetuximab + RGT-018 | Cetuximab RGT-018 | 0 | 0 |
| Cobimetinib + RGT-018 | Cobimetinib RGT-018 | 0 | 0 |
| Gefitinib + RGT-018 | Gefitinib RGT-018 | 0 | 0 |
| MRTX-1133 + RGT-018 | MRTX-1133 RGT-018 | 0 | 0 |
| RGT-018 | RGT-018 | 1 | 0 |
| RGT-018 + Sotorasib | RGT-018 Sotorasib | 0 | 0 |
| RGT-018 + Trametinib | RGT-018 Trametinib | 0 | 0 |